Implantology in patients affected by systemic diseases and on polypharmacy

被引:0
|
作者
Morelli, Chiara [1 ]
Salerno, Eleonora [1 ]
Pispero, Alberto [2 ]
Franchini, Roberto [2 ]
Lombardi, Niccolo [2 ]
机构
[1] Univ Milan, Dipartimento Sci Biomed Chirurg & Odontoiatr, Milan, Italy
[2] Univ Milan, ASST Santi Paolo & Carlo, Osped San Paolo, SC Odontostomatol 2,Dipartimento Sci Biomed Chiru, Milan, Italy
关键词
Polypharmacy; Systemic diseases; Implantology; Implant success; Implant complications; SEROTONIN REUPTAKE INHIBITORS; DENTAL IMPLANTS; MEDICATIONS; SURGERY; RISK; OSSEOINTEGRATION; PLACEMENT; SURVIVAL; OUTCOMES; IMPACT;
D O I
10.19256/d.cadmos.04.2022.05
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
OBJECTIVES The progressive increase in age in the general population, in the European Union and in particular in Italy, is necessarily leading dentists to interface with patients affected by multiple concomitant systemic diseases. These patients, who often are in polytherapy, increasingly require implant-prosthetic rehabilitation for their total or partial edentulousness. In these patients, prosthetic rehabilitation takes on an important significance, in order to guarantee a better quality of life and a re-appropriation of fundamental actions for social and psychological well-being such as eating, talking and smiling. Therefore, a careful study of the patient's medical history helps to minimize intra- and post-operative complications. The objective of this manuscript is to describe the relationship between systemic diseases, drug therapies and the decision-making process, as well as surgical rehabilitation, which every specialist must evaluate interfacing with a patient affected by systemic diseases and in drug polytherapy. MATERIALS AND METHODS This review emphasizes the importance of the patient's general health and the impact of drug therapies on implant rehabilitation. It is important to consider how some medical conditions can increase the risk of treatment failure or increase the risk of post-operative complications. Recent research of the scientific literature was carried out to guarantee, on the basis of up-to-date clinical data, useful advice to deal with the most common diseases and with their pharmacological therapies. Drug interactions in patients undergoing systemic polytherapy represent a problem which is difficult to manage even by healthcare professionals; therefore, adequate knowledge about drug therapies is a conditio sine qua non for a reliable implant rehabilitation surgery. CONCLUSIONS Polytherapy is crucial for the dentist who intends to deal with a patient with multiple systemic diseases and the continuous research, through the use of recent sources, allows to build a complete picture of the risk factors, the relative and absolute contraindications for this kind of rehabilitation, so as to reduce the risk of intra- and post-operative complications. In addition, the evaluation of the patients' medical condition ensures higher percentage of success and survival implant rate. CLINICAL SIGNIFICANCE It is imperative, in a population that has a high life expectancy and with an increasing incidence of chronic diseases, that the dentist is ready to deal with these patients with extreme accuracy. Scientific evidence is an important source that each dentist should analyze treating patients undergoing polytherapy to ensure the most predictable result. The knowledge on drug therapies and patient systemic diseases reduces the risk of errors and disputes in the community of dental practitioners; for this reason, each specialist should strive to acquire an education based on international scientific literature.
引用
收藏
页码:274 / 287
页数:14
相关论文
共 50 条
  • [21] Impact of polypharmacy on patients undergoing revascularisation for peripheral arterial disease
    Franke, Philipp
    Katsogridakis, Emmanuel
    Bisdas, Theodosios
    Saratzis, Athanasios
    Torsello, Giovanni
    Tsilimparis, Nikolaos
    Stavroulakis, Konstantinos
    VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2025, 54 (01) : 35 - 42
  • [22] Association of Polypharmacy with Colorectal Cancer Survival Among Older Patients
    Chen, Li-Ju
    Thi Ngoc Mai Nguyen
    Chang-Claude, Jenny
    Hoffmeister, Michael
    Brenner, Hermann
    Schoettker, Ben
    ONCOLOGIST, 2021, 26 (12): : E2170 - E2180
  • [23] Rates, variability, and associated factors of polypharmacy in nursing home patients
    Beloosesky, Yichayaou
    Nenaydenko, Olga
    Nevo, Revital Feige Gross
    Adunsky, Abraham
    Weiss, Avraham
    CLINICAL INTERVENTIONS IN AGING, 2013, 8 : 1585 - 1590
  • [24] Periodontal disease and systemic diseases in an older population
    Ozcaka, Ozgun
    Becerik, Sema
    Bicakci, Nurgun
    Kiyak, Asuman H.
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2014, 59 (02) : 474 - 479
  • [25] Systemic Bisphosphonate Application as a Risk Factor in Dental Implantology
    Stockmann, Philipp
    Wehrhan, Falk
    Fenner, Matthias
    Nkenke, Emeka
    IMPLANTOLOGIE, 2010, 18 (01): : 23 - 32
  • [26] Effects of chronic diseases and polypharmacy on death anxiety Polypharmacy on death anxiety
    Korkut, Burcu
    Sevinc, Nergiz
    ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2021, 12 : S338 - S342
  • [27] Impact of polypharmacy and comorbidity on survival and systemic parenteral treatment administration in a cohort of hospitalized lung-cancer patients
    Hélène Pluchart
    Sébastien Bailly
    Sébastien Chanoine
    Denis Moro-Sibilot
    Pierrick Bedouch
    Anne-Claire Toffart
    BMC Cancer, 23
  • [28] Impact of polypharmacy and comorbidity on survival and systemic parenteral treatment administration in a cohort of hospitalized lung-cancer patients
    Pluchart, Helene
    Bailly, Sebastien
    Chanoine, Sebastien
    Moro-Sibilot, Denis
    Bedouch, Pierrick
    Toffart, Anne-Claire
    BMC CANCER, 2023, 23 (01)
  • [29] Effectiveness of countermeasure for polypharmacy by multidisciplinary team review in patients with diabetes mellitus
    Nishida, Shohei
    Kato, Takehiro
    Hayashi, Yuichi
    Yamada, Shoya
    Fujii, Hironori
    Yamada, Michi
    Asai, Nao
    Shimizu, Shinya
    Niwa, Takashi
    Iihara, Hirotoshi
    Kubota, Sodai
    Sakai, Mayu
    Takahashi, Yoshihiro
    Takao, Ken
    Mizuno, Masami
    Hirota, Takuo
    Kobayashi, Ryo
    Horikawa, Yukio
    Yabe, Daisuke
    Suzuki, Akio
    JOURNAL OF DIABETES INVESTIGATION, 2023, 14 (10) : 1202 - 1208
  • [30] Mortality and causes of death across the systemic connective tissue diseases and the primary systemic vasculitides
    Garen, Torhild
    Lerang, Karoline
    Hoffmann-Vold, Anna-Maria
    Andersson, Helena
    Midtvedt, Oyvind
    Brunborg, Cathrine
    Kilian, Karin
    Gudbrandsson, Birgir
    Gunnarsson, Ragnar
    Norby, Gudrun
    Chaudhary, Asad
    Thoen, Jorn
    Forseth, Karin Oien
    Fresjar, Kari
    Forre, Oystein
    Haugen, Margaretha
    Haga, Hans-Jacob
    Gran, Jan Tore
    Gilboe, Inge-Margrethe
    Molberg, Oyvind
    Palm, Oyvind
    RHEUMATOLOGY, 2019, 58 (02) : 313 - 320